JP2012502398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502398A5 JP2012502398A5 JP2011527004A JP2011527004A JP2012502398A5 JP 2012502398 A5 JP2012502398 A5 JP 2012502398A5 JP 2011527004 A JP2011527004 A JP 2011527004A JP 2011527004 A JP2011527004 A JP 2011527004A JP 2012502398 A5 JP2012502398 A5 JP 2012502398A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- egci
- score
- level
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 22
- 230000007613 environmental effect Effects 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 230000002068 genetic effect Effects 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000004820 blood count Methods 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 210000004209 hair Anatomy 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 210000002200 mouth mucosa Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000000053 physical method Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Claims (20)
- 個体の疾患又は症状に関する環境遺伝複合指数(EGCI)スコアの作成方法であって、以下のステップ:
(a)前記個体の遺伝子サンプルからゲノムプロファイルを作成し;
(b)前記個体から少なくとも1つの環境因子を入手し、この場合、前記の少なくとも1つの環境因子が前記疾患又は症状に関して少なくとも1の相対リスクを有し;
(c)コンピューターを使用して、前記ゲノムプロファイルと前記の少なくとも1つの環境因子からEGCIスコアを作成し;そして
(d)前記コンピューターから入手し、出力した前記EGCIスコアを、前記個体又は前記個体のヘルスケア管理者に報告すること、
を含む、方法。 - 前記相対リスクが、少なくとも1.1、1.2、1.3、1.4、又は1.5である、請求項1に記載の方法。
- 前記相対リスクが、少なくとも2、3、4、5、10、12、15、20、25、30、25、40、45、又は50である、請求項1に記載の方法。
- 前記ORが、少なくとも1.1、1.2、1.3、1.4、又は1.5である、請求項1に記載の方法。
- 前記ORが、少なくとも2、3、4、5、10、12、15、20、25、30、35、40、45、又は50である、請求項1に記載の方法。
- 前記の少なくとも1つの環境因子が、前記個体の出生地、居住場所、ライフスタイル状況;食生活、運動習慣、及び個人的な人間関係から成る群から選択される、請求項1に記載の方法。
- 前記ライフスタイル状況が、喫煙又はアルコール摂取である、請求項6に記載の方法。
- 前記の少なくとも1つの環境因子が、前記個体の身体計測値である、請求項1に記載の方法。
- 前記身体計測値が、前記個体のボディーマスインデックス、血圧、心拍数、グルコースレベル、代謝物レベル、イオンレベル、体重、身長、コレステロールレベル、ビタミンレベル、血球数、タンパク質レベル、及び転写物レベルから成る群から選択される、請求項8に記載の方法。
- 前記EGCIスコアを作成するために、少なくとも2つの環境因子を使用する、請求項1に記載の方法。
- 前記EGCIスコアを作成するために、前記の疾患又は症状に関する前記の少なくとも1つの環境因子が独立リスクファクターであると仮定する、請求項1に記載の方法。
- 前記の疾患又は症状が、95%未満の遺伝率を有する、請求項1に記載の方法。
- 前記報告が、ネットワーク上での前記EGCIスコアの伝達を含む、請求項1に記載の方法。
- 前記報告が、オンラインポータル、紙又はeメールを通じてなされる、請求項1に記載の方法。
- 前記報告が、セキュリティー保護された様式での報告を含む、請求項1に記載の方法。
- 前記遺伝子サンプルが、DNAである、請求項1に記載の方法。
- 前記遺伝子サンプルが、RNAである、請求項1に記載の方法。
- 前記遺伝子サンプルが、血液、毛髪、皮膚、唾液、精液、尿、糞便、汗、及び口腔粘膜サンプルから成る群から選択される生体サンプル由来である、請求項1に記載の方法。
- 前記ゲノムプロファイルが、一塩基多型プロファイルである、請求項1に記載の方法。
- 前記ゲノムプロファイルが、トランケーション、挿入、欠失、又は反復を含んでなる、請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9675808P | 2008-09-12 | 2008-09-12 | |
US61/096,758 | 2008-09-12 | ||
PCT/US2009/056720 WO2010030929A1 (en) | 2008-09-12 | 2009-09-11 | Methods and systems for incorporating multiple environmental and genetic risk factors |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014151568A Division JP2015007985A (ja) | 2008-09-12 | 2014-07-25 | 複数の環境的リスク因子及び遺伝的リスク因子を組み込む方法及びシステム |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012502398A JP2012502398A (ja) | 2012-01-26 |
JP2012502398A5 true JP2012502398A5 (ja) | 2012-10-04 |
Family
ID=41381854
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011527004A Withdrawn JP2012502398A (ja) | 2008-09-12 | 2009-09-11 | 複数の環境的リスク因子及び遺伝的リスク因子を組み込む方法及びシステム |
JP2014151568A Pending JP2015007985A (ja) | 2008-09-12 | 2014-07-25 | 複数の環境的リスク因子及び遺伝的リスク因子を組み込む方法及びシステム |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014151568A Pending JP2015007985A (ja) | 2008-09-12 | 2014-07-25 | 複数の環境的リスク因子及び遺伝的リスク因子を組み込む方法及びシステム |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100070455A1 (ja) |
EP (1) | EP2335174A1 (ja) |
JP (2) | JP2012502398A (ja) |
KR (1) | KR20110074527A (ja) |
CN (1) | CN102187344A (ja) |
AU (1) | AU2009291577A1 (ja) |
BR (1) | BRPI0918889A2 (ja) |
GB (1) | GB2477868A (ja) |
TW (1) | TWI423151B (ja) |
WO (1) | WO2010030929A1 (ja) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103710429B (zh) | 2005-11-29 | 2016-03-30 | 剑桥企业有限公司 | 乳腺癌标志物 |
US20080131887A1 (en) * | 2006-11-30 | 2008-06-05 | Stephan Dietrich A | Genetic Analysis Systems and Methods |
US7844609B2 (en) | 2007-03-16 | 2010-11-30 | Expanse Networks, Inc. | Attribute combination discovery |
WO2009042975A1 (en) * | 2007-09-26 | 2009-04-02 | Navigenics, Inc. | Methods and systems for genomic analysis using ancestral data |
US9336177B2 (en) * | 2007-10-15 | 2016-05-10 | 23Andme, Inc. | Genome sharing |
US10275569B2 (en) | 2007-10-15 | 2019-04-30 | 22andMe, Inc. | Family inheritance |
US20090226912A1 (en) * | 2007-12-21 | 2009-09-10 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
US20100042438A1 (en) * | 2008-08-08 | 2010-02-18 | Navigenics, Inc. | Methods and Systems for Personalized Action Plans |
US8108406B2 (en) | 2008-12-30 | 2012-01-31 | Expanse Networks, Inc. | Pangenetic web user behavior prediction system |
EP3276526A1 (en) | 2008-12-31 | 2018-01-31 | 23Andme, Inc. | Finding relatives in a database |
EP2438193B1 (en) * | 2009-06-01 | 2015-07-22 | Genetic Technologies Limited | Methods for breast cancer risk assessment |
EP2504448B1 (en) * | 2009-11-25 | 2016-10-19 | Bio-Rad Laboratories, Inc. | Methods and compositions for detecting genetic material |
KR20110136638A (ko) * | 2010-06-15 | 2011-12-21 | 재단법인 게놈연구재단 | 게놈정보를 이용하여 온라인 상의 사회적 네트워크를 형성하는 시스템 및 그 형성방법 |
EP2611943B1 (en) | 2010-09-03 | 2017-01-04 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
TWI425928B (zh) * | 2010-11-11 | 2014-02-11 | E Da Hospital I Shou University | 個人健康風險評估方法 |
US9534256B2 (en) | 2011-01-06 | 2017-01-03 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer |
KR101268766B1 (ko) * | 2011-01-20 | 2013-05-29 | 순천향대학교 산학협력단 | 중증 천식의 악화 진단용 기상 및 대기 오염 인자의 위험도 예측방법 |
EP3940084A1 (en) | 2011-02-09 | 2022-01-19 | Bio-Rad Laboratories, Inc. | Analysis of nucleic acids |
EP2761520B1 (en) * | 2011-09-26 | 2020-05-13 | Trakadis, John | Diagnostic method and system for genetic disease search based on the phenotype and the genome of a human subject |
US8990250B1 (en) | 2011-10-11 | 2015-03-24 | 23Andme, Inc. | Cohort selection with privacy protection |
US10437858B2 (en) | 2011-11-23 | 2019-10-08 | 23Andme, Inc. | Database and data processing system for use with a network-based personal genetics services platform |
US10025877B2 (en) | 2012-06-06 | 2018-07-17 | 23Andme, Inc. | Determining family connections of individuals in a database |
TWI632518B (zh) * | 2012-07-12 | 2018-08-11 | 基龍米克斯生物科技股份有限公司 | 建立性格與基因關聯性模型的方法及其應用 |
US9977708B1 (en) | 2012-11-08 | 2018-05-22 | 23Andme, Inc. | Error correction in ancestry classification |
US9213947B1 (en) | 2012-11-08 | 2015-12-15 | 23Andme, Inc. | Scalable pipeline for local ancestry inference |
JP6268184B2 (ja) * | 2012-11-26 | 2018-01-24 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 患患者固有の関連性評価を用いた変異と疾患の関連付けを使用する診断的遺伝子分析 |
US10102333B2 (en) * | 2013-01-21 | 2018-10-16 | International Business Machines Corporation | Feature selection for efficient epistasis modeling for phenotype prediction |
US9910962B1 (en) * | 2013-01-22 | 2018-03-06 | Basehealth, Inc. | Genetic and environmental risk engine and methods thereof |
US9152920B2 (en) * | 2013-03-15 | 2015-10-06 | Yahoo! Inc. | System and method of event publication in a goal achievement platform |
EP3054412A4 (en) * | 2013-10-01 | 2017-03-01 | Tohoku University | Health information processing device, health information display device, and method |
CN105981024B (zh) * | 2013-12-12 | 2019-03-26 | Ab生物股份有限公司 | 用于提供关于药物使用的个性化推荐的基于网络的计算机辅助方法和系统及计算机可读介质 |
US20150269345A1 (en) * | 2014-03-19 | 2015-09-24 | International Business Machines Corporation | Environmental risk factor relevancy |
MX2017004127A (es) | 2014-09-30 | 2017-10-24 | Genetic Tech Limited | Metodos para evaluar el riesgo de desarrollar cancer de mama. |
US10296993B2 (en) | 2014-11-10 | 2019-05-21 | Conduent Business Services, Llc | Method and apparatus for defining performance milestone track for planned process |
GB2561300B (en) * | 2015-09-07 | 2021-03-10 | Global Gene Corp Pte Ltd | Method and system for diagnosing disease and generating treatment recommendations |
EP3350721A4 (en) * | 2015-09-18 | 2019-06-12 | Fabric Genomics, Inc. | PREDICTION OF DISEASE LOAD FROM GENOME VARIANTS |
JP6702686B2 (ja) * | 2015-10-09 | 2020-06-03 | 株式会社エムティーアイ | 表現型推定システム及び表現型推定プログラム |
US20170161837A1 (en) * | 2015-12-04 | 2017-06-08 | Praedicat, Inc. | User interface for latent risk assessment |
EP3475911A1 (en) * | 2016-06-22 | 2019-05-01 | Swiss Reinsurance Company Ltd. | Life insurance system with fully automated underwriting process for real-time underwriting and risk adjustment, and corresponding method thereof |
US10998103B2 (en) | 2016-10-06 | 2021-05-04 | International Business Machines Corporation | Medical risk factors evaluation |
US10892057B2 (en) | 2016-10-06 | 2021-01-12 | International Business Machines Corporation | Medical risk factors evaluation |
TWI607332B (zh) * | 2016-12-21 | 2017-12-01 | 國立臺灣師範大學 | Correlation between persistent organic pollutants and microRNAs station |
WO2018144320A1 (en) * | 2017-01-31 | 2018-08-09 | Counsyl, Inc. | Systems and methods for automatically generating genetic risk assessments |
US11404165B2 (en) * | 2017-03-30 | 2022-08-02 | Northeastern University | Foodome platform |
WO2018204414A1 (en) * | 2017-05-02 | 2018-11-08 | Human Longevity, Inc. | Genomics-based, technology-driven medicine platforms, systems, media, and methods |
KR102155776B1 (ko) * | 2017-09-13 | 2020-09-15 | 지니너스 주식회사 | 비만과 관련된 유전 정보를 이용한 개인 맞춤형 체지방 관리 방법 |
CN107680685A (zh) * | 2017-10-24 | 2018-02-09 | 山东浪潮云服务信息科技有限公司 | 一种疾病预警方法及系统 |
US11081217B2 (en) * | 2017-12-21 | 2021-08-03 | Basehealth, Inc. | Systems and methods for optimal health assessment and optimal preventive program development in population health management |
CN108346468B (zh) * | 2017-12-27 | 2021-03-23 | 北京科迅生物技术有限公司 | 数据处理方法及装置 |
GB201801137D0 (en) * | 2018-01-24 | 2018-03-07 | Fitnessgenes Ltd | Generating optimised workout plans using genetic and physiological data |
CN112074910A (zh) * | 2018-03-15 | 2020-12-11 | Arm有限公司 | 用于组学和/或行为内容处理的系统、装置和/或过程 |
US10841299B2 (en) | 2018-03-15 | 2020-11-17 | Arm Ltd. | Systems, devices, and/or processes for omic content processing and/or partitioning |
US10841083B2 (en) | 2018-03-15 | 2020-11-17 | Arm Ltd. | Systems, devices, and/or processes for OMIC content processing and/or communication |
US20210254164A1 (en) * | 2018-06-15 | 2021-08-19 | Opti-Thera Inc. | Polygenic risk scores for predicting disease complications and/or response to therapy |
US11527331B2 (en) | 2018-06-15 | 2022-12-13 | Xact Laboratories, LLC | System and method for determining the effectiveness of medications using genetics |
US11380424B2 (en) | 2018-06-15 | 2022-07-05 | Xact Laboratories Llc | System and method for genetic based efficacy testing |
US11398312B2 (en) | 2018-06-15 | 2022-07-26 | Xact Laboratories, LLC | Preventing the fill of ineffective or under-effective medications through integration of genetic efficacy testing results with legacy electronic patient records |
US11227685B2 (en) | 2018-06-15 | 2022-01-18 | Xact Laboratories, LLC | System and method for laboratory-based authorization of genetic testing |
KR102188968B1 (ko) * | 2018-08-24 | 2020-12-09 | 주식회사 클리노믹스 | 환경적 요인 변화에 따른 질병 발생 위험도 변동 시각화 장치 및 방법 |
US20200074313A1 (en) * | 2018-08-29 | 2020-03-05 | Koninklijke Philips N.V. | Determining features to be included in a risk assessment instrument |
AU2019370896A1 (en) | 2018-10-31 | 2021-06-17 | Ancestry.Com Dna, Llc | Estimation of phenotypes using DNA, pedigree, and historical data |
US10468141B1 (en) | 2018-11-28 | 2019-11-05 | Asia Genomics Pte. Ltd. | Ancestry-specific genetic risk scores |
KR102311269B1 (ko) * | 2018-12-13 | 2021-10-12 | 주식회사 케이티 | 건강 정보 관리 서버, 이를 이용한 건강 정보 관리 방법 및 컴퓨터 프로그램 |
EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
US11587651B2 (en) | 2019-03-08 | 2023-02-21 | Merative Us L.P. | Person-centric genomic services framework and integrated genomics platform and systems |
CN113905660A (zh) * | 2019-03-19 | 2022-01-07 | 瑟姆巴股份有限公司 | 使用亲属的信息确定非孟德尔表型的遗传风险 |
CA3147888A1 (en) | 2019-07-19 | 2021-01-28 | 23Andme, Inc. | Phase-aware determination of identity-by-descent dna segments |
KR102091790B1 (ko) * | 2019-09-02 | 2020-03-20 | 주식회사 클리노믹스 | 피검사자와 생물체 간의 유전자 정보를 이용한 유전적 띠 제공 시스템 및 그 방법 |
CA3154157A1 (en) | 2019-09-13 | 2021-03-18 | 23Andme, Inc. | Methods and systems for determining and displaying pedigrees |
TWI715250B (zh) | 2019-10-17 | 2021-01-01 | 宏碁股份有限公司 | 特徵識別方法與電子裝置 |
JP7084658B2 (ja) * | 2020-01-24 | 2022-06-15 | 株式会社ブーリアン | 動物用遺伝子性疾患予防食品提案システム |
JP7212640B2 (ja) * | 2020-03-11 | 2023-01-25 | 日清食品ホールディングス株式会社 | 食品情報提供システム、装置、方法及びプログラム |
US11289206B2 (en) * | 2020-06-02 | 2022-03-29 | Kpn Innovations, Llc. | Artificial intelligence methods and systems for constitutional analysis using objective functions |
US20220199259A1 (en) * | 2020-06-02 | 2022-06-23 | Kpn Innovations, Llc. | Artificial intelligence methods and systems for constitutional analysis using objective functions |
US11817176B2 (en) | 2020-08-13 | 2023-11-14 | 23Andme, Inc. | Ancestry composition determination |
US11461193B2 (en) * | 2020-09-24 | 2022-10-04 | International Business Machines Corporation | Data storage volume recovery management |
CA3194288A1 (en) | 2020-10-09 | 2022-04-14 | 23Andme, Inc. | Formatting and storage of genetic markers |
US20220189637A1 (en) * | 2020-12-11 | 2022-06-16 | Cerner Innovation, Inc. | Automatic early prediction of neurodegenerative diseases |
US12112244B2 (en) | 2020-12-29 | 2024-10-08 | Kpn Innovations, Llc. | System and method for generating a procreant functional program |
US11049603B1 (en) | 2020-12-29 | 2021-06-29 | Kpn Innovations, Llc. | System and method for generating a procreant nourishment program |
US11145401B1 (en) | 2020-12-29 | 2021-10-12 | Kpn Innovations, Llc. | Systems and methods for generating a sustenance plan for managing genetic disorders |
US11735310B2 (en) | 2020-12-29 | 2023-08-22 | Kpn Innovations, Llc. | Systems and methods for generating a parasitic infection nutrition program |
US11355229B1 (en) | 2020-12-29 | 2022-06-07 | Kpn Innovations, Llc. | System and method for generating an ocular dysfunction nourishment program |
US20220273233A1 (en) * | 2021-02-26 | 2022-09-01 | Hi Llc | Brain Activity Derived Formulation of Target Sleep Routine for a User |
US11935642B2 (en) | 2021-03-01 | 2024-03-19 | Kpn Innovations, Llc | System and method for generating a neonatal disorder nourishment program |
US11854685B2 (en) | 2021-03-01 | 2023-12-26 | Kpn Innovations, Llc. | System and method for generating a gestational disorder nourishment program |
CN113284622A (zh) * | 2021-05-27 | 2021-08-20 | 四川大学华西医院 | 一种低龄儿童龋风险评估方法、系统及存储介质 |
WO2022260129A1 (ja) * | 2021-06-09 | 2022-12-15 | 国立大学法人京都大学 | 情報処理装置、情報処理方法、及びプログラム |
WO2023102539A1 (en) * | 2021-12-03 | 2023-06-08 | Washington State University | Dna methylation biomarkers for rheumatoid arthritis |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192659A (en) * | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US5958684A (en) * | 1995-10-02 | 1999-09-28 | Van Leeuwen; Frederik Willem | Diagnosis of neurodegenerative disease |
US6703228B1 (en) * | 1998-09-25 | 2004-03-09 | Massachusetts Institute Of Technology | Methods and products related to genotyping and DNA analysis |
US6730023B1 (en) * | 1999-10-15 | 2004-05-04 | Hemopet | Animal genetic and health profile database management |
US6640211B1 (en) * | 1999-10-22 | 2003-10-28 | First Genetic Trust Inc. | Genetic profiling and banking system and method |
US20020133495A1 (en) * | 2000-03-16 | 2002-09-19 | Rienhoff Hugh Y. | Database system and method |
US6660476B2 (en) * | 2000-05-02 | 2003-12-09 | City Of Hope | Polymorphisms in the PNMT gene |
WO2002033520A2 (en) * | 2000-10-18 | 2002-04-25 | Genomic Health, Inc. | Genomic profile information systems and methods |
US20080261220A1 (en) * | 2000-11-30 | 2008-10-23 | Third Wave Technologies, Inc. | Nucleic Acid Detection Assays |
US20020128860A1 (en) * | 2001-01-04 | 2002-09-12 | Leveque Joseph A. | Collecting and managing clinical information |
US20030054381A1 (en) * | 2001-05-25 | 2003-03-20 | Pfizer Inc. | Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
US20040121320A1 (en) * | 2001-08-07 | 2004-06-24 | Genelink, Inc. | Use of genetic information to detect a predisposition for bone density conditions |
US20030040002A1 (en) * | 2001-08-08 | 2003-02-27 | Ledley Fred David | Method for providing current assessments of genetic risk |
US7072794B2 (en) * | 2001-08-28 | 2006-07-04 | Rockefeller University | Statistical methods for multivariate ordinal data which are used for data base driven decision support |
US7461006B2 (en) * | 2001-08-29 | 2008-12-02 | Victor Gogolak | Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data |
US20060188875A1 (en) * | 2001-09-18 | 2006-08-24 | Perlegen Sciences, Inc. | Human genomic polymorphisms |
AU2002363329A1 (en) * | 2001-11-06 | 2003-05-19 | Elizabeth Gray | Pharmacogenomics-based system for clinical applications |
US20030219776A1 (en) * | 2001-12-18 | 2003-11-27 | Jean-Marc Lalouel | Molecular variants, haplotypes and linkage disequilibrium within the human angiotensinogen gene |
US20040002818A1 (en) * | 2001-12-21 | 2004-01-01 | Affymetrix, Inc. | Method, system and computer software for providing microarray probe data |
US20060160074A1 (en) * | 2001-12-27 | 2006-07-20 | Third Wave Technologies, Inc. | Pharmacogenetic DME detection assay methods and kits |
WO2003074048A1 (en) * | 2002-03-01 | 2003-09-12 | Warner-Lambert Company Llc | Method of treating osteoarthritis |
US7135286B2 (en) * | 2002-03-26 | 2006-11-14 | Perlegen Sciences, Inc. | Pharmaceutical and diagnostic business systems and methods |
US20040115701A1 (en) * | 2002-08-30 | 2004-06-17 | Comings David E | Method for risk assessment for polygenic disorders |
EP1585433A4 (en) * | 2002-09-25 | 2008-01-23 | Ge Healthcare Sv Corp | DETECTION METHODS |
WO2004044225A2 (en) * | 2002-11-11 | 2004-05-27 | Affymetrix, Inc. | Methods for identifying dna copy number changes |
JP2004173505A (ja) * | 2002-11-22 | 2004-06-24 | Mitsuo Itakura | 疾患感受性遺伝子の同定方法並びにそれに用いるプログラムおよびシステム |
US20060257888A1 (en) * | 2003-02-27 | 2006-11-16 | Methexis Genomics, N.V. | Genetic diagnosis using multiple sequence variant analysis |
US20050037366A1 (en) * | 2003-08-14 | 2005-02-17 | Joseph Gut | Individual drug safety |
CA3048093A1 (en) * | 2003-11-26 | 2005-06-23 | Celera Corporation | Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |
US20050214811A1 (en) * | 2003-12-12 | 2005-09-29 | Margulies David M | Processing and managing genetic information |
US20060046256A1 (en) * | 2004-01-20 | 2006-03-02 | Applera Corporation | Identification of informative genetic markers |
US7983932B2 (en) * | 2004-02-17 | 2011-07-19 | BodyBio, Inc | Network and methods for integrating individualized clinical test results and nutritional treatment |
US7127355B2 (en) * | 2004-03-05 | 2006-10-24 | Perlegen Sciences, Inc. | Methods for genetic analysis |
TWI364600B (en) * | 2004-04-12 | 2012-05-21 | Kuraray Co | An illumination device an image display device using the illumination device and a light diffusing board used by the devices |
US20060278241A1 (en) * | 2004-12-14 | 2006-12-14 | Gualberto Ruano | Physiogenomic method for predicting clinical outcomes of treatments in patients |
US20060184489A1 (en) * | 2004-12-17 | 2006-08-17 | General Electric Company | Genetic knowledgebase creation for personalized analysis of medical conditions |
US20060166224A1 (en) * | 2005-01-24 | 2006-07-27 | Norviel Vernon A | Associations using genotypes and phenotypes |
US20070122824A1 (en) * | 2005-09-09 | 2007-05-31 | Tucker Mark R | Method and Kit for Assessing a Patient's Genetic Information, Lifestyle and Environment Conditions, and Providing a Tailored Therapeutic Regime |
US7695911B2 (en) * | 2005-10-26 | 2010-04-13 | Celera Corporation | Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof |
US20070196344A1 (en) * | 2006-01-20 | 2007-08-23 | The Procter & Gamble Company | Methods for identifying materials that can help regulate the condition of mammalian keratinous tissue |
US8340950B2 (en) * | 2006-02-10 | 2012-12-25 | Affymetrix, Inc. | Direct to consumer genotype-based products and services |
US20080131887A1 (en) * | 2006-11-30 | 2008-06-05 | Stephan Dietrich A | Genetic Analysis Systems and Methods |
EP2102651A4 (en) * | 2006-11-30 | 2010-11-17 | Navigenics Inc | GENERALYSIS SYSTEMS AND METHODS |
WO2009042975A1 (en) * | 2007-09-26 | 2009-04-02 | Navigenics, Inc. | Methods and systems for genomic analysis using ancestral data |
US20090182579A1 (en) * | 2008-01-10 | 2009-07-16 | Edison Liu | Method of processing genomic information |
US20090198519A1 (en) * | 2008-01-31 | 2009-08-06 | Mcnamar Richard Timothy | System for gene testing and gene research while ensuring privacy |
US20100042438A1 (en) * | 2008-08-08 | 2010-02-18 | Navigenics, Inc. | Methods and Systems for Personalized Action Plans |
-
2009
- 2009-09-11 JP JP2011527004A patent/JP2012502398A/ja not_active Withdrawn
- 2009-09-11 AU AU2009291577A patent/AU2009291577A1/en not_active Abandoned
- 2009-09-11 CN CN2009801408119A patent/CN102187344A/zh active Pending
- 2009-09-11 KR KR1020117008292A patent/KR20110074527A/ko not_active Application Discontinuation
- 2009-09-11 US US12/558,345 patent/US20100070455A1/en not_active Abandoned
- 2009-09-11 GB GB1104128A patent/GB2477868A/en not_active Withdrawn
- 2009-09-11 BR BRPI0918889A patent/BRPI0918889A2/pt not_active IP Right Cessation
- 2009-09-11 EP EP09792478A patent/EP2335174A1/en not_active Ceased
- 2009-09-11 WO PCT/US2009/056720 patent/WO2010030929A1/en active Application Filing
- 2009-09-14 TW TW098130958A patent/TWI423151B/zh not_active IP Right Cessation
-
2014
- 2014-07-25 JP JP2014151568A patent/JP2015007985A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012502398A5 (ja) | ||
Wu et al. | Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue | |
Aro et al. | Saliva liquid biopsy for point-of-care applications | |
Rotti et al. | Determinants of prakriti, the human constitution types of Indian traditional medicine and its correlation with contemporary science | |
Oh et al. | Biogeography and individuality shape function in the human skin metagenome | |
Bouchard et al. | Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study | |
Filges et al. | Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel–Giedion syndrome | |
Warren et al. | Heritability and linkage analysis of hand, foot, and eye preference in Mexican Americans | |
WO2006105252A3 (en) | Diagnosis of chronic pulmonary obstructive disease and monitoring of therapy using gene expression analysis of peripheral blood cells | |
Vogtmann et al. | Temporal variability of oral microbiota over 10 months and the implications for future epidemiologic studies | |
Wu et al. | Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study | |
Wang et al. | Comparison of the performance of Ion Torrent chips in noninvasive prenatal trisomy detection | |
Silva et al. | Morphological and molecular evidence for two new species of Tetragonopterus (Characiformes: Characidae) from central Brazil | |
Kumagai et al. | Sequence and unique phylogeny of G genes of bovine respiratory syncytial viruses circulating in Japan | |
CN107937516A (zh) | 一种环状rna标志物及其应用 | |
Zhou et al. | Variants in KCNQ1, AP3S1, MAN2A1, and ALDH7A1 and the risk of type 2 diabetes in the Chinese Northern Han population: a case-control study and meta-analysis | |
Moyad | Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part II. | |
Yoo et al. | Genetic polymorphisms to predict gains in maximal O 2 uptake and knee peak torque after a high intensity training program in humans | |
Young | Sort by | |
Delfini et al. | Systematics and phylogenetic placement of Panicum L. species within the Melinidinae based on morphological, anatomical, and molecular data (Poaceae, Panicoideae, Paniceae) | |
JP2011107124A (ja) | 生体情報取得方法 | |
Murch et al. | 1165 The wales infants’ and children’s genome service’(WINGS): diagnostic rapid whole genome sequencing for unwell children with a suspected rare genetic diagnosis | |
CN105200131A (zh) | 基于14个snp位点评估外周动脉疾病患病风险的试剂盒 | |
KR101673148B1 (ko) | 운동 민감도 예측용 바이오마커 | |
Schlecht | Oral human papillomavirus infection: hazard of intimacy |